Laurie Beth Friesenhahn Stellman, PhD

Patent Agent
Norton Rose Fulbright US LLP
laurie.stellman@nortonrosefulbright.com
Laurie Friesenhahn
Stellman
Laurie Beth Friesenhahn Stellman, PhD
Austin
Suite 1100
98 San Jacinto Boulevard
Austin
Texas
78701-4255
United States
+1 512 536 3072

A patent agent in the Austin office, Laurie's experience centers on foreign and domestic patent prosecution in the areas of biotechnology and pharmaceuticals. She has handled matters relating to biotechnology, immunology, cancer therapy, gene therapy, pharmaceuticals, molecular bioassays, drug screening and targeting, pharmaceutical and cosmetic formulations, medical devices, biofuels, genetic engineering and stem cells.

Awards and recognitions

  • Legal 500 US, Recommended Lawyer, Education,  The Legal 500,  2025

Education

PhD, Biology, Massachusetts Institute of Technology, 2008
BS, cum laude, Biochemistry, Genetics, Texas A&M University, 2002

Laurie was registered in 2010 with the U.S. Patent and Trademark Office.

Admissions

  • US Patent and Trademark Agent

Publications

  • *Co-First Authorship, *Friesenhahn LB, *Danielian PS, Faust AM, West JC, Caron AM, Bronson RT, Lees JA; "E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity," Oncogene; 27(51):6561-70, November 20, 2008
  • *Co-First Authorship, *Friesenhahn LB, *Courel M, Lees, JA; "E2f6 and Bmi1 cooperate in axial skeletal development," Developmental Dynamics; 237(5):1232-1242, May 2008
  • Carvin CD, Dhasarathy A, Friesenhahn LB, Jessen WJ, Kladde MP; "Targeted cytosine methylation for in vivo detection of protein-DNA interactions," Proceedings of the National Academy of Sciences of the United States of America;100(13):7743-8, 2003
Bio